Liminatus Pharma Inc. Issues 350,000 Shares in Exchange for Cancellation of 1,000,000 Warrants with Alta Partners

Reuters
Jul 18
Liminatus Pharma Inc. Issues 350,000 Shares in Exchange for Cancellation of 1,000,000 Warrants with Alta Partners

Liminatus Pharma Inc. has entered into a settlement and release agreement with Alta Partners, LLC, resulting in the issuance of 350,000 shares of its common stock to Alta Partners in exchange for the cancellation of 1,000,000 warrants to purchase shares of common stock. The shares have a par value of $0.0001 each. No commission or remuneration was involved in this transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-068670), on July 17, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10